Neopharma is a prominent pharmaceutical manufacturing brand based in the UAE, honoring the esteemed Father of the Nation, His Highness Sheikh Zayed Bin Sultan Al Nahyan. Since its establishment in 2003 with an initial investment of USD25 million, Neopharma has strived to produce top-quality pharmaceuticals at accessible prices. With 10 manufacturing facilities across the globe, including in Canada, UAE, Brazil, Japan, and India, Neopharma offers a wide range of branded and generic formulations, APIs, and over 100 high-quality molecules catering to various therapeutic segments.

The brand places a strong emphasis on innovation and research to develop patent non-infringing products. Neopharma serves more than 50 international markets in the Middle East, Africa, CIS, Far East, and South East Asia, embodying a commitment to global healthcare excellence. Led by Dr.

B. R. Shetty, Neopharma continues to make significant strides in the pharmaceutical industry, ensuring quality and care in every product